Net Savings Link, Inc. Appoints Dato' Sri Desmond Lim as Senior Vice President
May 19, 2021
Share
Net Savings Link, Inc. announced the appointment of Mr. Dato' Sri Desmond Lim as Senior Vice President of Cryptocurrency Operations. Mr. Lim is the Co-Founder of the World Glove City Project in Malaysia. He is also vice president of (UTIC) LianXin Holding Finance Shenzhen Group and a partner in the leading investment banking firm, Silverbear Capital Inc. Mr. Lim has extensive finance and fund management experience and is instrumental in turnkey and financial solutions for Silverbear's private clients. He has access to numerous global fund managers across the board, in the US, Europe, China, Hong Kong, Singapore and Malaysia. Under his portfolio projects, Mr. Lim is responsible for Corporate exercise, Pre-IPO, implementing investment strategy and managing portfolio trading activities to provide the best returns to investors and stakeholders. Mr. Lim is also a vice president of China Overseas Holding Group, a Board of Director of Virtual Currency Philippine Inc., a Malaysia Myfintech Foundation Board of Trustee and CEO of Golden Fortune Shenzhen Inc., a public listed company in Shenzhen, China.
Net Savings Link, Inc. is a cryptocurrency, blockchain and digital asset technology company. Its primary focus is to make acquisitions and deals in the cryptocurrency sector. It provides turnkey technological solutions to the cryptocurrency, blockchain and digital asset industries. It focuses on providing a range of services, such as software solutions, e-commerce, advisory services, financial services, and information technology. It owns NSAV Premium OTC Cryptocurrency Trading Desk, https://nsavholdinginc.com/otc-desk/, NSAV Decentralized Cryptocurrency Exchange, NSAVDEX 1 https://nsavdex.org/#/home running on Okex Chain, NSAV Decentralized Cryptocurrency Exchange, NSAVDEX 2 https://nsavdex.io/ running on Binance Smart Chain, and others. The Company, through its subsidiary, Shanghai Hua Si Tai Medical Consultation Company Limited, provides clinical research to companies, such as Eli Lilly and the Medtronic Foundation. Its primary markets include the United States, Europe, and China.